Literature DB >> 11460169

Cdc6 cooperates with Sic1 and Hct1 to inactivate mitotic cyclin-dependent kinases.

A Calzada1, M Sacristán, E Sánchez, A Bueno.   

Abstract

Exit from mitosis requires the inactivation of mitotic cyclin-dependent kinases (CDKs). In the budding yeast, Saccharomyces cerevisiae, inactivation of CDKs during late mitosis involves degradation of B-type cyclins as well as direct inhibition of cyclin-CDK complexes by the CDK-inhibitor protein Sic1 (refs 1,2,3). Several striking similarities exist between Sic1 and Cdc6, a DNA replication factor essential for the formation of pre-replicative complexes at origins of DNA replication. Transcription of both genes is activated during late mitosis by a process dependent on Swi5 (ref. 10). Like Sic1, Cdc6 binds CDK complexes in vivo and downregulates them in vitro. Here we show that Cdc6, like Sic1, also contributes to inactivation of CDKs during late mitosis in S. cerevisiae. Deletion of the CDK-interacting domain of Cdc6 does not inhibit the function of origins of DNA replication during S phase, but instead causes a delay in mitotic exit; this delay is accentuated in the absence of Sic1 or of cyclin degradation. By contributing to mitotic exit and inactivation of CDKs, Cdc6 helps to create the conditions that are required for its subsequent role in the formation of pre-replicative complexes at origins of DNA replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11460169     DOI: 10.1038/35085610

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

1.  Regulation of the final stage of mitosis by components of the pre-replicative complex and a polo kinase.

Authors:  Hyungshin Yim; Raymond L Erikson
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

2.  Integrative analysis of cell cycle control in budding yeast.

Authors:  Katherine C Chen; Laurence Calzone; Attila Csikasz-Nagy; Frederick R Cross; Bela Novak; John J Tyson
Journal:  Mol Biol Cell       Date:  2004-05-28       Impact factor: 4.138

Review 3.  Regulating DNA replication in eukarya.

Authors:  Khalid Siddiqui; Kin Fan On; John F X Diffley
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

4.  Cell division cycle 6, a mitotic substrate of polo-like kinase 1, regulates chromosomal segregation mediated by cyclin-dependent kinase 1 and separase.

Authors:  Hyungshin Yim; Raymond L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

5.  Decoding ubiquitin for mitosis.

Authors:  Sadek Fournane; Ksenia Krupina; Charlotte Kleiss; Izabela Sumara
Journal:  Genes Cancer       Date:  2012-11

6.  Binding of cyclin-dependent kinases to ORC and Cdc6p regulates the chromosome replication cycle.

Authors:  M Weinreich; C Liang; H H Chen; B Stillman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

7.  Regulation of CDC6, geminin, and CDT1 in human cells that undergo polyploidization.

Authors:  Rodrigo Bermejo; Nuria Vilaboa; Carmela Calés
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

8.  Deregulated Cdc6 inhibits DNA replication and suppresses Cdc7-mediated phosphorylation of Mcm2-7 complex.

Authors:  Lena R Kundu; Yuji Kumata; Naoko Kakusho; Saori Watanabe; Asako Furukohri; Shou Waga; Masayuki Seki; Hisao Masai; Takemi Enomoto; Shusuke Tada
Journal:  Nucleic Acids Res       Date:  2010-04-26       Impact factor: 16.971

9.  Genetic and biochemical evaluation of the importance of Cdc6 in regulating mitotic exit.

Authors:  Vincent Archambault; Caihong X Li; Alan J Tackett; Ralph Wasch; Brian T Chait; Michael P Rout; Frederick R Cross
Journal:  Mol Biol Cell       Date:  2003-09-05       Impact factor: 4.138

10.  Human replication protein Cdc6 prevents mitosis through a checkpoint mechanism that implicates Chk1.

Authors:  Lorena Clay-Farrace; Cristina Pelizon; David Santamaria; Jonathon Pines; Ronald A Laskey
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.